Jotec GmbH
Clinical trials sponsored by Jotec GmbH, explained in plain language.
A medical device company specializing in vascular implants, acquired by CryoLife.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Researchers check safety of stent grafts used in aortic aneurysm surgery Results expected Sep 2026 (estimated)
-
New stent graft aims to fix aneurysms without major surgery
Disease control CompletedThis study tested a special stent graft (E-liac) to treat bulges in the iliac artery (aneurysms) without open surgery. 71 patients received the device, sometimes combined with other aortic grafts. The main goal was to prevent aneurysm rupture and death. Researchers tracked succes…
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Tailored stents show promise for Hard-to-Treat aneurysms
Disease control CompletedThis study looked at 47 people with thoracoabdominal aortic aneurysms (a bulge in the main artery in the chest and belly). They received a custom-made stent graft (a fabric-covered metal tube) designed to fit their unique anatomy. The goal was to see if the aneurysm size stayed s…
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC